Merdury Biopharmaceutical Corporation (TPEX:6932)
8.14
-0.19 (-2.28%)
Apr 29, 2026, 9:29 AM CST
-41.01% (1Y)
| Market Cap | 3.52B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -67.23M |
| Shares Out | 422.03M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 634,666 |
| Open | 8.33 |
| Previous Close | 8.33 |
| Day's Range | 8.14 - 8.33 |
| 52-Week Range | 4.95 - 13.80 |
| Beta | -1.62 |
| RSI | 56.78 |
| Earnings Date | May 14, 2026 |